← Open Payments lookup

KAT BALINGIT: Open Payments

NPI 1538790605 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,736 in 95 payments from 10 companies in 2025. Trend: 2023 $2,219 · 2024 $1,910 · 2025 $2,736

Food & beverage: $2,736
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$589
Alkermes, Inc.17$481
Neurocrine BioSciences, Inc.14$352
Vanda Pharmaceuticals Inc.6$305
Otsuka America Pharmaceutical, Inc.12$288
E.R. Squibb & Sons, L.L.C.11$272
Janssen Pharmaceuticals, Inc7$264
Teva Pharmaceuticals USA, Inc.5$110
ABBVIE INC.3$56
Lundbeck LLC1$19

Products named: CAPLYTA, ARISTADA, INGREZZA, COBENFY, HETLIOZ, FANAPT, ABILIFY MAINTENA, LYBALVI.

Industry payments across CA — which companies pay providers there.